IRIDEX Corporation (IRIX)
Largest Insider Buys in Sector
IRIX Stock Price History Chart
IRIX Stock Performance
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
Insider Activity of IRIDEX Corporation
Over the last 12 months, insiders at IRIDEX Corporation have bought $0 and sold $0 worth of IRIDEX Corporation stock.
On average, over the past 5 years, insiders at IRIDEX Corporation have bought $68,980 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $6,200 was made by Devi Nandini () on 2022‑05‑20.
List of Insider Buy and Sell Transactions, IRIDEX Corporation
| 2022-05-20 | Devi Nandini | 2,000 0.0126% | $3.10 | $6,200 | -24.68% | |||
| 2022-03-16 | Devi Nandini | 2,000 0.0122% | $4.20 | $8,400 | -41.86% | |||
| 2021-12-02 | Grove Robert Earle | director | 1,644 0.0102% | $6.08 | $9,999 | -49.59% | ||
| 2021-11-16 | Devi Nandini | director | 1,000 0.0064% | $7.73 | $7,730 | -56.27% | ||
| 2020-05-15 | Grove Robert Earle | director | 15,125 0.1082% | $1.68 | $25,446 | +44.22% | ||
| 2019-11-18 | Grove Robert Earle | director | 14,600 0.0911% | $2.04 | $29,749 | +0.49% | ||
| 2019-11-15 | Grove Robert Earle | director | 10,000 0.0625% | $2.02 | $20,187 | +1.49% | ||
| 2019-11-14 | Shuda Scott | director | 10,000 0.0625% | $2.02 | $20,200 | +1.49% | ||
| 2019-11-13 | Shuda Scott | director | 5,000 0.0311% | $2.01 | $10,050 | +1.49% | ||
| 2018-12-13 | Grove Robert Earle | director | 863 0.0054% | $4.30 | $3,711 | -0.82% | ||
| 2018-12-12 | MOORE WILLIAM M | Chairman and CEO | 10,000 0.0642% | $4.34 | $43,443 | +0.59% | ||
| 2018-12-12 | Grove Robert Earle | director | 3,684 0.0235% | $4.32 | $15,903 | +0.59% | ||
| 2018-12-11 | Grove Robert Earle | director | 4,673 0.0298% | $4.18 | $19,542 | +3.78% | ||
| 2018-12-10 | Grove Robert Earle | director | 2,500 0.0156% | $4.17 | $10,432 | +1.55% | ||
| 2018-11-27 | MOORE WILLIAM M | Chairman and CEO | 10,000 0.062% | $4.71 | $47,144 | -8.11% | ||
| 2018-09-18 | PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 70,000 0.4375% | $6.00 | $420,000 | -22.00% | |||
| 2018-09-14 | MOORE WILLIAM M | Chairman and CEO | 10,000 0.0613% | $6.56 | $65,600 | -29.97% | ||
| 2018-03-13 | Sale | Dizon Romeo R | 2,806 0.0166% | $5.86 | $16,444 | -6.77% | ||
| 2017-12-12 | MOORE WILLIAM M | Chairman and CEO | 5,000 0.0318% | $7.84 | $39,200 | -15.82% | ||
| 2017-09-15 | MOORE WILLIAM M | Chairman and CEO | 1,800 0.0109% | $9.42 | $16,956 | -23.20% |
Insider Historical Profitability
| BlueLine Catalyst Fund IX, L.P. | 2559122 15.7506% | $2.21 | 18 | 0 | +10.43% | |
| BlueLine Capital Partners II, L.P. | 10 percent owner | 2508100 15.4366% | $2.21 | 2 | 0 | +27.27% |
| BlueLine Partners, L.L.C. | 10 percent owner | 2465222 15.1727% | $2.21 | 9 | 0 | |
| Acuta Capital Fund, LP | 10 percent owner | 1344720 8.2763% | $2.21 | 33 | 0 | <0.0001% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 1320000 8.1242% | $2.21 | 17 | 0 | +39.25% | |
| MOORE WILLIAM M | Chairman and CEO | 206800 1.2728% | $2.21 | 48 | 0 | +3.67% |
| BOUTACOFF THEODORE A | President, CEO and Chairman | 159047 0.9789% | $2.21 | 1 | 19 | |
| Grove Robert Earle | director | 93364 0.5746% | $2.21 | 8 | 0 | +0.21% |
| DONOVAN JAMES L | VP Corp Business Development | 82510 0.5078% | $2.21 | 0 | 1 | |
| Steckel Ronald | VP, Operations | 65625 0.4039% | $2.21 | 0 | 30 | |
| NAUMANN-ETIENNE RUEDIGER | director | 64433 0.3966% | $2.21 | 4 | 11 | +37.2% |
| Mackaness James H | CFO and COO | 45052 0.2773% | $2.21 | 1 | 31 | |
| GARRETTSON GARRETT A | director | 39441 0.2427% | $2.21 | 5 | 2 | +27.37% |
| HAWKINS JAMES B | director | 31294 0.1926% | $2.21 | 0 | 4 | |
| HAMMOND DONALD L | director | 23750 0.1462% | $2.21 | 0 | 4 | |
| Dizon Romeo R | 22483 0.1384% | $2.21 | 0 | 8 | ||
| Shuda Scott | director | 15000 0.0923% | $2.21 | 2 | 0 | +1.49% |
| Devi Nandini | 10420 0.0641% | $2.21 | 3 | 0 | <0.0001% | |
| Caldwell Barry G | President and CEO | 6000 0.0369% | $2.21 | 1 | 0 | <0.0001% |
| Marcellino George R | director | 1289 0.0079% | $2.21 | 0 | 1 | |
| ARIAS EDUARDO | Sr. VP, Global Sales | 0 0% | $2.21 | 0 | 17 | |
| FITCH SANFORD | director | 0 0% | $2.21 | 4 | 1 | +5.46% |
| Todd Donald J | Sr. VP of Marketing | 0 0% | $2.21 | 0 | 1 | |
| POWERS TIMOTHY S | VP, Operations | 0 0% | $2.21 | 0 | 2 |
Institutional Investor Ownership
| Paragon Associates Paragon Associates Ii Joint Venture | $2.98M | 6.15 | 1M | 0% | +$0 | 5.31 | |
| The Vanguard Group | $1.67M | 3.45 | 561,096 | +0.7% | +$11,613.06 | <0.0001 | |
| Amh Equity Ltd | $1.36M | 2.81 | 456,400 | +15.25% | +$179,992.00 | 1.7 | |
| Renaissance Technologies | $1.22M | 2.52 | 410,160 | -1.18% | -$14,598.69 | <0.01 | |
| Geode Capital Management | $359,765.00 | 0.74 | 120,694 | 0% | +$0 | <0.0001 | |
| ARS Investment Partners, LLC | $327,994.00 | 0.68 | 110,065 | +0.29% | +$962.54 | 0.03 | |
| Long Focus Capital Management Llc | $298,000.00 | 0.62 | 100,000 | 0% | +$0 | 0.04 | |
| Susquehanna International Group | $254,412.00 | 0.53 | 85,373 | -19.53% | -$61,754.65 | <0.0001 | |
| Bridgeway Capital Management | $229,758.00 | 0.47 | 77,100 | 0% | +$0 | <0.01 | |
| Apexium Financial LP | $195,771.00 | 0.4 | 65,695 | 0% | +$0 | 0.02 | |
| BlackRock | $162,124.00 | 0.34 | 54,404 | -2.63% | -$4,371.66 | <0.0001 | |
| Dimensional Fund Advisors | $144,015.00 | 0.3 | 48,327 | 0% | +$0 | <0.0001 | |
| Perkins Capital Management Inc | $135,000.00 | 0.28 | 45,300 | +12.97% | +$15,496.69 | 0.12 | |
| State Street | $133,260.00 | 0.28 | 44,718 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $115,922.00 | 0.24 | 38,900 | +453.26% | +$94,969.62 | <0.0001 | |
| BNY Mellon | $93,989.00 | 0.19 | 31,540 | -9.09% | -$9,395.92 | <0.0001 | |
| Northern Trust | $83,869.00 | 0.17 | 28,144 | -0.74% | -$625.80 | <0.0001 | |
| Wolverine Trading | $48,511.00 | 0.1 | 16,279 | -6.63% | -$3,441.87 | <0.0001 | |
| Hightower Advisors | $30,000.00 | 0.06 | 10,000 | 0% | +$0 | <0.0001 | |
| Simplex Trading Llc | $20,000.00 | 0.04 | 6,743 | +89.09% | +$9,423.10 | <0.01 | |
| Group One Trading | $16,211.00 | 0.03 | 5,440 | +1,136.36% | +$14,899.82 | <0.0001 | |
| Tower Research Capital | $5,995.00 | 0.01 | 2,012 | +126.32% | +$3,346.12 | <0.0001 | |
| Advisor Group Holdings Inc | $2,980.00 | 0.01 | 1,000 | 0% | +$0 | <0.0001 | |
| Venturi Private Wealth | $2,235.00 | 0.01 | 750 | 0% | +$0 | <0.0001 | |
| Morgan Stanley | $2,056.00 | <0.01 | 690 | 0% | +$0 | <0.0001 | |
| UBS | $563.00 | <0.01 | 189 | -97.22% | -$19,666.28 | <0.0001 | |
| Wells Fargo | $292.00 | <0.01 | 98 | +2.08% | +$5.96 | <0.0001 | |
| JPMorgan Chase | $95.00 | <0.01 | 32 | -87.79% | -$682.81 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 30 | -80.52% | -$0 | <0.0001 |